Filing Flows › OptimizeRx (OPRX) › Q2 2026
OptimizeRx (OPRX) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 13, 2026
OptimizeRx (OPRX) reported revenue of $20.5M for the second quarter 2026 (Q2 2026), -30% from a year earlier and +3% from the quarter before. Operating margin was -0.4%, net loss $703K (3.4% of revenue).
OptimizeRx, Q2 2026: revenue $20.5M (-30% year over year), operating margin -0.4%, net loss $703K, operating cash flow $8.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.5M | +3% | -30% |
| Operating profit | −$88K | -122% | -103% |
| Net earnings | −$703K | — | -146% |
| Operating cash flow | $8.6M | — | +89% |
| Free cash flow | $8.6M | — | +88% |
What changed
Revenue was $20.5M in Q2 2026, down 30% year over year and up 3% from the previous quarter.
Operating costs exceeded revenue by $88K, an operating margin of -0.4%. The fastest-growing cost line was Other operating costs (+28%). The quarter ended with a net loss of $703K, wider than the previous quarter's $495K loss. Net interest and other expense of $1.0M was the main reason.
Operating cash flow was $8.6M (up 89% year over year). Non-cash charges added back $1.1M of depreciation and amortization and $2.2M of share-based compensation. Working capital and other items added $6.0M. Capital expenditures of $35K left free cash flow of $8.6M.
Questions
What was OptimizeRx's revenue in the second quarter 2026?
OptimizeRx (OPRX) reported revenue of $20.5M for the second quarter 2026 (Q2 2026), -30% from a year earlier and +3% from the quarter before.
Was OptimizeRx profitable in the second quarter 2026?
Operating loss was $88K (-0.4% of revenue) and net loss $703K.
Source: OptimizeRx 10-Q on SEC EDGAR.